Literature summary extracted from

Talieri, M.; Alexopoulou, D.K.; Scorilas, A.; Kypraios, D.; Arnogiannaki, N.; Devetzi, M.; Patsavela, M.; Xynopoulos, D.
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer (2011), Tumour Biol., 32, 737-744.

Application

EC Number	Application	Comment	Organism
3.4.21.B41	medicine	high status KLK10 expression is a significant factor for disease-free survival and overall survival of colorectal cancer patients. KLK10 gene expression may be used as a marker of unfavorable prognosis for colorectal cancer	Homo sapiens

Organism

EC Number	Organism	UniProt	Comment	Textmining
3.4.21.B41	Homo sapiens	-	-	-

Source Tissue

EC Number	Source Tissue	Comment	Organism	Textmining
3.4.21.B41	Caco-2 cell	-	Homo sapiens	-
3.4.21.B41	colorectal carcinoma cell	-	Homo sapiens	-
3.4.21.B41	DLD-1 cell	-	Homo sapiens	-
3.4.21.B41	HCT-116 cell	-	Homo sapiens	-
3.4.21.B41	HT-29 cell	-	Homo sapiens	-
3.4.21.B41	LS-180 cell	-	Homo sapiens	-

Synonyms

EC Number	Synonyms	Comment	Organism
3.4.21.B41	kallikrein-related peptidase 10	-	Homo sapiens
3.4.21.B41	KLK10	-	Homo sapiens

Expression

EC Number	Organism	Comment	Expression
3.4.21.B41	Homo sapiens	KLK10 expression is significantly higher in cancerous than in normal colorectal tissues	up

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)